A citation-based method for searching scientific literature

Katie M O'Brien, Stephen R Cole, Chiu-Kit Tse, Charles M Perou, Lisa A Carey, William D Foulkes, Lynn G Dressler, Joseph Geradts, Robert C Millikan. Clin Cancer Res 2010
Times Cited: 273







List of co-cited articles
456 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Lisa A Carey, Charles M Perou, Chad A Livasy, Lynn G Dressler, David Cowan, Kathleen Conway, Gamze Karaca, Melissa A Troester, Chiu Kit Tse, Sharon Edmiston,[...]. JAMA 2006
30

Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.
Erica T Warner, Rulla M Tamimi, Melissa E Hughes, Rebecca A Ottesen, Yu-Ning Wong, Stephen B Edge, Richard L Theriault, Douglas W Blayney, Joyce C Niland, Eric P Winer,[...]. J Clin Oncol 2015
163
19

US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.
Nadia Howlader, Sean F Altekruse, Christopher I Li, Vivien W Chen, Christina A Clarke, Lynn A G Ries, Kathleen A Cronin. J Natl Cancer Inst 2014
663
15

Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
14

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
13

Supervised risk predictor of breast cancer based on intrinsic subtypes.
Joel S Parker, Michael Mullins, Maggie C U Cheang, Samuel Leung, David Voduc, Tammi Vickery, Sherri Davies, Christiane Fauron, Xiaping He, Zhiyuan Hu,[...]. J Clin Oncol 2009
12

Breast cancer statistics, 2015: Convergence of incidence rates between black and white women.
Carol E DeSantis, Stacey A Fedewa, Ann Goding Sauer, Joan L Kramer, Robert A Smith, Ahmedin Jemal. CA Cancer J Clin 2016
772
12


Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.
Mary Jo Lund, Katrina F Trivers, Peggy L Porter, Ralph J Coates, Brian Leyland-Jones, Otis W Brawley, Elaine W Flagg, Ruth M O'Regan, Sheryl G A Gabram, J William Eley. Breast Cancer Res Treat 2009
271
11


Breast cancer statistics, 2017, racial disparity in mortality by state.
Carol E DeSantis, Jiemin Ma, Ann Goding Sauer, Lisa A Newman, Ahmedin Jemal. CA Cancer J Clin 2017
886
11

Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.
Dezheng Huo, Hai Hu, Suhn K Rhie, Eric R Gamazon, Andrew D Cherniack, Jianfang Liu, Toshio F Yoshimatsu, Jason J Pitt, Katherine A Hoadley, Melissa Troester,[...]. JAMA Oncol 2017
137
10

Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States.
Javaid Iqbal, Ophira Ginsburg, Paula A Rochon, Ping Sun, Steven A Narod. JAMA 2015
352
10


Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study.
Melissa A Troester, Xuezheng Sun, Emma H Allott, Joseph Geradts, Stephanie M Cohen, Chiu-Kit Tse, Erin L Kirk, Leigh B Thorne, Michelle Mathews, Yan Li,[...]. J Natl Cancer Inst 2018
63
15

Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities.
Carol E DeSantis, Rebecca L Siegel, Ann Goding Sauer, Kimberly D Miller, Stacey A Fedewa, Kassandra I Alcaraz, Ahmedin Jemal. CA Cancer J Clin 2016
493
9

Epidemiology of basal-like breast cancer.
Robert C Millikan, Beth Newman, Chiu-Kit Tse, Patricia G Moorman, Kathleen Conway, Lynn G Dressler, Lisa V Smith, Miriam H Labbok, Joseph Geradts, Jeannette T Bensen,[...]. Breast Cancer Res Treat 2008
622
8

Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.
Betsy A Kohler, Recinda L Sherman, Nadia Howlader, Ahmedin Jemal, A Blythe Ryerson, Kevin A Henry, Francis P Boscoe, Kathleen A Cronin, Andrew Lake, Anne-Michelle Noone,[...]. J Natl Cancer Inst 2015
489
8

Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
Huiyan Ma, Yani Lu, Kathleen E Malone, Polly A Marchbanks, Dennis M Deapen, Robert Spirtas, Ronald T Burkman, Brian L Strom, Jill A McDonald, Suzanne G Folger,[...]. BMC Cancer 2013
34
23

Racial/Ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic review.
Megan C Roberts, Stephanie B Wheeler, Katherine Reeder-Hayes. Am J Public Health 2015
71
11

Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study.
Li Tao, Scarlett Lin Gomez, Theresa H M Keegan, Allison W Kurian, Christina A Clarke. Cancer Epidemiol Biomarkers Prev 2015
72
11



A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L Baehner, Michael G Walker, Drew Watson, Taesung Park,[...]. N Engl J Med 2004
7

Triple-negative breast cancer: clinical features and patterns of recurrence.
Rebecca Dent, Maureen Trudeau, Kathleen I Pritchard, Wedad M Hanna, Harriet K Kahn, Carol A Sawka, Lavina A Lickley, Ellen Rawlinson, Ping Sun, Steven A Narod. Clin Cancer Res 2007
7

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, Mitch Dowsett, Lisa M McShane, Kimberly H Allison, Donald C Allred, John M S Bartlett, Michael Bilous, Patrick Fitzgibbons,[...]. J Clin Oncol 2013
7

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Soonmyung Paik, Gong Tang, Steven Shak, Chungyeul Kim, Joffre Baker, Wanseop Kim, Maureen Cronin, Frederick L Baehner, Drew Watson, John Bryant,[...]. J Clin Oncol 2006
6

The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology.
B Newman, P G Moorman, R Millikan, B F Qaqish, J Geradts, T E Aldrich, E T Liu. Breast Cancer Res Treat 1995
172
6


Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status.
Lisa A Newman, Kent A Griffith, Ismail Jatoi, Michael S Simon, Joseph P Crowe, Graham A Colditz. J Clin Oncol 2006
255
6

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.
Brian D Lehmann, Joshua A Bauer, Xi Chen, Melinda E Sanders, A Bapsi Chakravarthy, Yu Shyr, Jennifer A Pietenpol. J Clin Invest 2011
6

Differences in breast cancer stage, treatment, and survival by race and ethnicity.
Christopher I Li, Kathleen E Malone, Janet R Daling. Arch Intern Med 2003
509
6

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.
Joseph A Sparano, Robert J Gray, Della F Makower, Kathleen I Pritchard, Kathy S Albain, Daniel F Hayes, Charles E Geyer, Elizabeth C Dees, Edith A Perez, John A Olson,[...]. N Engl J Med 2015
780
6

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.
Maggie C U Cheang, Stephen K Chia, David Voduc, Dongxia Gao, Samuel Leung, Jacqueline Snider, Mark Watson, Sherri Davies, Philip S Bernard, Joel S Parker,[...]. J Natl Cancer Inst 2009
6


Molecular classification and molecular forecasting of breast cancer: ready for clinical application?
James D Brenton, Lisa A Carey, Ahmed Ashour Ahmed, Carlos Caldas. J Clin Oncol 2005
636
6

Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study.
Luc Y Dirix, Istvan Takacs, Guy Jerusalem, Petros Nikolinakos, Hendrik-Tobias Arkenau, Andres Forero-Torres, Ralph Boccia, Marc E Lippman, Robert Somer, Martin Smakal,[...]. Breast Cancer Res Treat 2018
337
6

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
6

Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial.
Joseph A Sparano, Molin Wang, Fengmin Zhao, Vered Stearns, Silvana Martino, Jennifer A Ligibel, Edith A Perez, Tom Saphner, Antonio C Wolff, George W Sledge,[...]. J Natl Cancer Inst 2012
68
8

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
Joseph A Sparano, Robert J Gray, Della F Makower, Kathleen I Pritchard, Kathy S Albain, Daniel F Hayes, Charles E Geyer, Elizabeth C Dees, Matthew P Goetz, John A Olson,[...]. N Engl J Med 2018
901
6

Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast Cancer.
Megan C Roberts, Morris Weinberger, Stacie B Dusetzina, Michaela A Dinan, Katherine E Reeder-Hayes, Lisa A Carey, Melissa A Troester, Stephanie B Wheeler. J Clin Oncol 2016
37
13

Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics.
Carol Sweeney, Philip S Bernard, Rachel E Factor, Marilyn L Kwan, Laurel A Habel, Charles P Quesenberry, Kaylynn Shakespear, Erin K Weltzien, Inge J Stijleman, Carole A Davis,[...]. Cancer Epidemiol Biomarkers Prev 2014
77
6

Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
Kathy S Albain, Joseph M Unger, John J Crowley, Charles A Coltman, Dawn L Hershman. J Natl Cancer Inst 2009
340
5

Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression.
Candyce H Kroenke, Carol Sweeney, Marilyn L Kwan, Charles P Quesenberry, Erin K Weltzien, Laurel A Habel, Adrienne Castillo, Phillip S Bernard, Rachel E Factor, Lawrence H Kushi,[...]. Breast Cancer Res Treat 2014
28
17

Race, response to chemotherapy, and outcome within clinical breast cancer subtypes.
J R Tichy, A M Deal, C K Anders, K Reeder-Hayes, L A Carey. Breast Cancer Res Treat 2015
30
16

Breast cancer intrinsic subtype classification, clinical use and future trends.
Xiaofeng Dai, Ting Li, Zhonghu Bai, Yankun Yang, Xiuxia Liu, Jinling Zhan, Bozhi Shi. Am J Cancer Res 2015
438
5

Treatment quality and outcomes of African American versus white breast cancer patients: retrospective analysis of Southwest Oncology studies S8814/S8897.
Dawn L Hershman, Joseph M Unger, William E Barlow, Laura F Hutchins, Silvana Martino, C Kent Osborne, Robert B Livingston, Kathy S Albain. J Clin Oncol 2009
94
5

Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities.
Garth H Rauscher, Abigail Silva, Heather Pauls, Jonna Frasor, Marcelo G Bonini, Kent Hoskins. Breast Cancer Res Treat 2017
20
25

Clinical implications of the intrinsic molecular subtypes of breast cancer.
Aleix Prat, Estela Pineda, Barbara Adamo, Patricia Galván, Aranzazu Fernández, Lydia Gaba, Marc Díez, Margarita Viladot, Ana Arance, Montserrat Muñoz. Breast 2015
418
5



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.